TheLondonteam advised General Catalyst, Bertelsmann Investments, and Meridian Health Ventures on the sale of Phare Health to R1, an industry leader in managing and intelligently automating healthcare revenue management. The transaction marks a significant step in advancing R1's strategy to leverage cutting-edge AI capabilities to comprehensively automate the revenue cycle and move closer to real-time adjudication of medical claims.
General Catalystis a global investment and transformation company that partners with the world's most ambitious entrepreneurs to drive resilience and applied AI.
Bertelsmann Investmentsis a global investment platform dedicated to driving best-in-class returns and encouraging entrepreneurship worldwide. With decades committed to venture and several billion in assets under management, the company partners with leading entrepreneurs and venture funds across stages and sectors, operating dedicated funds in India, China, Europe, the US, and other growth regions. Bertelsmann Investments' commitment to building leading businesses is further realized through the growth program Bertelsmann Next, which is home to their own incubation efforts and buy-and-build strategies.
Meridian Health Venturesis the first NHS-anchored and transatlantic venture capital fund, investing in clinical innovators and enabling adoption of transformative solutions at scale.
The Goodwin team was made up ofCarl Bradshaw,Emily Townsend,Stefania Athannassopoulou,Laura Antuna-Ortega,George Fagan,Harriet Worthington, Oliver Watt,Patrick Mitchell,Meggie Hickey,Andy BartonandDulcie Daly.
For more information on the deal, please read thepress release.